Skip to main content

Hurley Ariel's Form 4 filing

Blueprint Medicines Corp (BPMC) · filed Dec 16, 2024

Accession no.
0001415889-24-029518
Filed
Dec 16, 2024
Trade date
Dec 12, 2024
Filing delay
4 days
Rule 10b5-1 plan
Checked

This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $169.6K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Hurley ArielCIK 0001769740Officer (PRINCIPAL ACCOUNTING OFFICER)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 12, 2024Common StockMOption exerciseAcquired+1,600$15.01+$24,01616,786Direct
Dec 12, 2024Common StockSSaleDisposed−1,200$92.88−$111,45615,586Direct
Dec 12, 2024Common StockSSaleDisposed−619$93.99−$58,179.8114,967Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Dec 12, 2024Common StockMOption exerciseDisposed−1,600$15.01−$24,0160Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)